Literature DB >> 28733216

SLDAssay: A software package and web tool for analyzing limiting dilution assays.

Ilana M Trumble1, Andrew G Allmon2, Nancie M Archin3, Joseph Rigdon4, Owen Francis2, Pedro L Baldoni2, Michael G Hudgens2.   

Abstract

Serial limiting dilution (SLD) assays are used in many areas of infectious disease related research. This paper presents SLDAssay, a free and publicly available R software package and web tool for analyzing data from SLD assays. SLDAssay computes the maximum likelihood estimate (MLE) for the concentration of target cells, with corresponding exact and asymptotic confidence intervals. Exact and asymptotic goodness of fit p-values, and a bias-corrected (BC) MLE are also provided. No other publicly available software currently implements the BC MLE or the exact methods. For validation of SLDAssay, results from Myers et al. (1994) are replicated. Simulations demonstrate the BC MLE is less biased than the MLE. Additionally, simulations demonstrate that exact methods tend to give better confidence interval coverage and goodness-of-fit tests with lower type I error than the asymptotic methods. Additional advantages of using exact methods are also discussed.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dilution assay; HIV; Infectious units; Latency; Maximum likelihood estimation; Software

Mesh:

Year:  2017        PMID: 28733216      PMCID: PMC5595663          DOI: 10.1016/j.jim.2017.07.004

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Design and analysis of serial limiting dilution assays with small sample sizes.

Authors:  C Macken
Journal:  J Immunol Methods       Date:  1999-01-01       Impact factor: 2.303

2.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.

Authors:  Amanda M Crooks; Rosalie Bateson; Anna B Cope; Noelle P Dahl; Morgan K Griggs; JoAnn D Kuruc; Cynthia L Gay; Joseph J Eron; David M Margolis; Ronald J Bosch; Nancie M Archin
Journal:  J Infect Dis       Date:  2015-04-15       Impact factor: 5.226

3.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

4.  HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.

Authors:  Nancy M Archin; Rosalie Bateson; Manoj K Tripathy; Amanda M Crooks; Kuo-Hsiung Yang; Noelle P Dahl; Mary F Kearney; Elizabeth M Anderson; John M Coffin; Matthew C Strain; Douglas D Richman; Kevin R Robertson; Angela D Kashuba; Ronald J Bosch; Daria J Hazuda; Joann D Kuruc; Joseph J Eron; David M Margolis
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

5.  Dilution assay statistics.

Authors:  L E Myers; L J McQuay; F B Hollinger
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

7.  Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.

Authors:  Natalia Soriano-Sarabia; Nancie M Archin; Rosalie Bateson; Noelle P Dahl; Amanda M Crooks; JoAnn D Kuruc; Carolina Garrido; David M Margolis
Journal:  PLoS Pathog       Date:  2015-10-16       Impact factor: 6.823

Review 8.  Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1.

Authors:  Daniel I S Rosenbloom; Oliver Elliott; Alison L Hill; Timothy J Henrich; Janet M Siliciano; Robert F Siliciano
Journal:  Open Forum Infect Dis       Date:  2015-08-26       Impact factor: 3.835

  8 in total
  14 in total

1.  Assessment of replicate numbers for titrating avian influenza virus using dose-response models.

Authors:  Erica Spackman; Sasidhar Malladi; Amos Ssematimba; Christopher B Stephens
Journal:  J Vet Diagn Invest       Date:  2019-05-25       Impact factor: 1.279

2.  Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy.

Authors:  Shane D Falcinelli; Bonnie E Shook-Sa; Morgan G Dewey; Sumati Sridhar; Jenna Read; Jennifer Kirchherr; Katherine S James; Brigitte Allard; Simon Ghofrani; Erin Stuelke; Caroline Baker; Nadia R Roan; Joseph J Eron; JoAnn D Kuruc; Catalina Ramirez; Cynthia Gay; Katie R Mollan; David M Margolis; Adaora A Adimora; Nancie M Archin
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

3.  Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy.

Authors:  Shane D Falcinelli; Kayla W Kilpatrick; Jenna Read; Ross Murtagh; Brigitte Allard; Simon Ghofrani; Jennifer Kirchherr; Katherine S James; Erin Stuelke; Caroline Baker; JoAnn D Kuruc; Joseph J Eron; Michael G Hudgens; Cynthia L Gay; David M Margolis; Nancie M Archin
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

4.  A two-stage experimental design for dilution assays.

Authors:  Jake M Ferguson; Tanya A Miura; Craig R Miller
Journal:  Biometrics       Date:  2019-04-03       Impact factor: 2.571

5.  Computational Evaluation of B-Cell Clone Sizes in Bulk Populations.

Authors:  Aaron M Rosenfeld; Wenzhao Meng; Dora Y Chen; Bochao Zhang; Tomer Granot; Donna L Farber; Uri Hershberg; Eline T Luning Prak
Journal:  Front Immunol       Date:  2018-06-29       Impact factor: 7.561

6.  Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size.

Authors:  Sherazaan D Ismail; Catherine Riou; Sarah B Joseph; Nancie M Archin; David M Margolis; Alan S Perelson; Tyler Cassidy; Melissa-Rose Abrahams; Matthew Moeser; Olivia D Council; Lyle R McKinnon; Farzana Osman; Quarraisha Abdool Karim; Salim S Abdool Karim; Ronald Swanstrom; Carolyn Williamson; Nigel J Garrett; Wendy A Burgers
Journal:  Clin Infect Dis       Date:  2021-10-20       Impact factor: 20.999

7.  HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy.

Authors:  Yinyan Xu; Ilana M Trumble; Joanna A Warren; Genevieve Clutton; Maria Abad-Fernandez; Jennifer Kirchnerr; Adaora A Adimora; Steven G Deeks; David M Margolis; JoAnn D Kuruc; Cynthia L Gay; Nancie M Archin; Katie R Mollan; Michael Hudgens; Nilu Goonetilleke
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-14       Impact factor: 6.698

8.  Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir.

Authors:  Jason Neidleman; Xiaoyu Luo; Julie Frouard; Guorui Xie; Feng Hsiao; Tongcui Ma; Vincent Morcilla; Ashley Lee; Sushama Telwatte; Reuben Thomas; Whitney Tamaki; Benjamin Wheeler; Rebecca Hoh; Ma Somsouk; Poonam Vohra; Jeffrey Milush; Katherine Sholtis James; Nancie M Archin; Peter W Hunt; Steven G Deeks; Steven A Yukl; Sarah Palmer; Warner C Greene; Nadia R Roan
Journal:  Elife       Date:  2020-09-29       Impact factor: 8.140

9.  Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.

Authors:  Christopher C Nixon; Maud Mavigner; Gavin C Sampey; Alyssa D Brooks; Rae Ann Spagnuolo; David M Irlbeck; Cameron Mattingly; Phong T Ho; Nils Schoof; Corinne G Cammon; Greg K Tharp; Matthew Kanke; Zhang Wang; Rachel A Cleary; Amit A Upadhyay; Chandrav De; Saintedym R Wills; Shane D Falcinelli; Cristin Galardi; Hasse Walum; Nathaniel J Schramm; Jennifer Deutsch; Jeffrey D Lifson; Christine M Fennessey; Brandon F Keele; Sherrie Jean; Sean Maguire; Baolin Liao; Edward P Browne; Robert G Ferris; Jessica H Brehm; David Favre; Thomas H Vanderford; Steven E Bosinger; Corbin D Jones; Jean-Pierre Routy; Nancie M Archin; David M Margolis; Angela Wahl; Richard M Dunham; Guido Silvestri; Ann Chahroudi; J Victor Garcia
Journal:  Nature       Date:  2020-01-22       Impact factor: 49.962

10.  Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.

Authors:  Cynthia L Gay; Joann D Kuruc; Shane D Falcinelli; Joanna A Warren; Sarah A Reifeis; Jennifer L Kirchherr; Katherine S James; Morgan G Dewey; Alyson Helms; Brigitte Allard; Erin Stuelke; Alicia Gamble; Ana Plachco; Robert J Gorelick; Joseph J Eron; Michael Hudgens; Carolina Garrido; Nilu Goonetilleke; Mark A DeBenedette; Irina Y Tcherepanova; Charles A Nicolette; Nancie M Archin; David M Margolis
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.